A research team at Massachusetts Eye and Ear has shown that microglia, the primary immune cells of the brain and retina, play a protective role in response to retinal detachment. Retinal detachment and subsequent degeneration ...
Jun 18, 2018
0
157
The loss of tiny cells in the inner ear, known as "hair cells," is a leading cause of hearing loss, a public health problem affecting at least one out of three people over the age of 65. Of the two varieties of hair cells, ...
May 14, 2018
0
108
Massachusetts Eye and Ear researchers have shown that mifepristone, a drug currently FDA-approved for chemical abortion, prevents the growth of vestibular schwannoma (also known as acoustic neuroma) cells. This sometimes-lethal ...
Apr 3, 2018
0
9
Massachusetts Eye and Ear made medical history on Tuesday by performing the first post-FDA approval gene therapy for patients with a form of inherited blindness. The occasion marks the beginning of a new era in medicine, ...
Mar 20, 2018
0
702
Head and neck tumors that contain cells undergoing a partial epithelial-to-mesenchymal transition—which transforms them from neatly organized blocks into irregular structures that extrude into the surrounding environment—are ...
Nov 30, 2017
0
0
Patients with any stage of age-related macular degeneration (AMD) carry signs of the disease in their blood that may be found through special laboratory tests, according to a new study led by AMD researchers based at Massachusetts ...
Sep 12, 2017
0
93
A compound of specific bioactive products from a major family of enzymes reduced the severity of age-related macular degeneration (AMD) in a preclinical model, according to a new study led by Massachusetts Eye and Ear researchers. ...
Aug 21, 2017
0
43
A research team from the Schepens Eye Research Institute of Massachusetts Eye and Ear has successfully prevented mice from developing angiogenesis of the retina—the sensory tissue at the back of the eye—using gene-editing ...
Jul 24, 2017
0
66
Patients with chronic rhinosinusitis (CRS) who quit smoking will see their condition improve over a period of about 10 years, according to the results of a new study led by the Sinus Center at Mass. Eye and Ear. The study, ...
Jul 12, 2017
0
0
Treating donor corneas with a cocktail of molecules prior to transplanting to a host may improve survival of grafts and, thus, outcomes in high-risk corneal transplant patients, according to a new study led by researchers ...
May 1, 2017
0
0
